Independent Pharmacies of Maryland
Maryland could cap prices for Ozempic and other diabetes drugs
Pa. legislators passed a law to regulate pharmacy middlemen. But the state doesn’t enforce it.
3Axis Report Scrutinizes PBM Spread Pricing Practice
Op-Ed: Health care middlemen don’t benefit NJ patients or pharmacists
The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Independent pharmacists start ads asking Congress for relief from PBMs, ask Supreme Court to hear a case
Miyares joins cohort pressing for U.S. Supreme Court to review pharmacy benefit manager case
PHARMACIES: PBMs are killing independent owners
As pharmacies shutter, some Western states, Black and Latino communities are left behind
Patients, pharmacists march against PBM business model
Congress needs to stop pharmacy benefit managers from wrongly impeding access to drugs
Navarro Announces Completion of First Pharmacy Benefit Manager Exams
UnitedHealth Group CEO takes bipartisan heat in Senate hearing over cyberattack
Chains Feeling the Squeeze
David Balto: End the link between PBMs and drug prices
Nearly a third of independent pharmacies at risk of closure in 2024
The Truth Behind Medicare (Dis)Advantage's Disinformation Campaign | Opinion
Commentary: How lawmakers can protect copay assistance
Years later, states' drug pricing boards have yet to bring down costs
The PBM-insurer mafia comes for community pharmacies